These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 34032961)
21. Anaplastic thyroid carcinoma: a 25-year single-institution experience. Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064 [TBL] [Abstract][Full Text] [Related]
22. Radio(chemo)therapy in anaplastic thyroid cancer-high locoregional but low distant control rates-a monocentric analysis of a tertiary referral center. Schmied M; Lettmaier S; Semrau S; Traxdorf M; Mantsopoulos K; Mueller SK; Iro H; Denz A; Grützmann R; Fietkau R; Haderlein M Strahlenther Onkol; 2022 Nov; 198(11):994-1001. PubMed ID: 35522270 [TBL] [Abstract][Full Text] [Related]
23. Thyroid anaplastic carcinoma: the impact of multimodality treatment on survival. The experience of a referral center for endocrine surgery. Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Sole Di Patrizi M; Barillaro I; Boccolini A; Sanguinetti A; Avenia N Minerva Chir; 2014 Oct; 69(5):261-9. PubMed ID: 25052058 [TBL] [Abstract][Full Text] [Related]
24. Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases. Liu TR; Xiao ZW; Xu HN; Long Z; Wei FQ; Zhuang SM; Sun XM; Xie LE; Mu JS; Yang AK; Zhang GP; Fan Y PLoS One; 2016; 11(10):e0164840. PubMed ID: 27760217 [TBL] [Abstract][Full Text] [Related]
26. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma. Lee DY; Won JK; Choi HS; Park do J; Jung KC; Sung MW; Kim KH; Hah JH; Park YJ Thyroid; 2016 Sep; 26(9):1259-68. PubMed ID: 27412715 [TBL] [Abstract][Full Text] [Related]
27. The role of surgery in anaplastic thyroid cancer: A systematic review. Hu S; Helman SN; Hanly E; Likhterov I Am J Otolaryngol; 2017; 38(3):337-350. PubMed ID: 28366512 [TBL] [Abstract][Full Text] [Related]
28. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study. Oliinyk D; Augustin T; Rauch J; Koehler VF; Belka C; Spitzweg C; Käsmann L J Cancer Res Clin Oncol; 2023 Jul; 149(7):3527-3547. PubMed ID: 35960373 [TBL] [Abstract][Full Text] [Related]
29. Anaplastic thyroid cancer: An update. Rao SN; Smallridge RC Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101678. PubMed ID: 35668021 [TBL] [Abstract][Full Text] [Related]
30. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma. Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309 [TBL] [Abstract][Full Text] [Related]
31. Anaplastic thyroid cancer in young patients: a contemporary review. Li M; Milas M; Nasr C; Brainard JA; Khan MJ; Burkey BB; Scharpf J Am J Otolaryngol; 2013; 34(6):636-40. PubMed ID: 23993450 [TBL] [Abstract][Full Text] [Related]
32. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study. Lee JH; Ahn HK; Seok JY; Lee KC; Chun YS; Chung YS; Lee YD Medicine (Baltimore); 2018 Jun; 97(25):e11037. PubMed ID: 29923991 [TBL] [Abstract][Full Text] [Related]
33. Tracheal stenting has minimal impact on survival in anaplastic thyroid carcinoma. Rajeev P; Ezzat T; Slade M; Sadler GP; Mihai R World J Surg; 2013 Nov; 37(11):2589-93. PubMed ID: 23912397 [TBL] [Abstract][Full Text] [Related]
34. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma. Gómez Sáez JM; Jiménez-Fonseca P; Santamaría Sandi J; Capdevila Castillón J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Riesco Eizaguirre G; Grande Pulido E; Galofré Ferrater JC Endocrinol Nutr; 2015 Mar; 62(3):e15-22. PubMed ID: 25583658 [TBL] [Abstract][Full Text] [Related]
35. Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Higashiyama T; Ito Y; Hirokawa M; Fukushima M; Uruno T; Miya A; Matsuzuka F; Miyauchi A Thyroid; 2010 Jan; 20(1):7-14. PubMed ID: 20025538 [TBL] [Abstract][Full Text] [Related]
36. Case Report: 84-Month Disease-Free Survival after Surgery for Anaplastic Thyroid Carcinoma. Kanazawa S; Kammori M J Nippon Med Sch; 2019; 86(1):38-42. PubMed ID: 30918155 [TBL] [Abstract][Full Text] [Related]
38. Time trend in tumour size and characteristics of anaplastic thyroid carcinoma. Han JM; Bae Kim W; Kim TY; Ryu JS; Gong G; Hong SJ; Kim JH; Oh YL; Jang HW; Kim SW; Chung JH; Shong YK Clin Endocrinol (Oxf); 2012 Sep; 77(3):459-64. PubMed ID: 22458627 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching. Lee J; Park JH; Lee CR; Chung WY; Park CS Thyroid; 2013 Nov; 23(11):1408-15. PubMed ID: 23509895 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of anaplastic thyroid carcinoma in the Kurdistan region of Iraq. Mustafa DH; Ahmed BS; Haweizy RM; Dewana AM BMC Surg; 2022 Oct; 22(1):364. PubMed ID: 36271386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]